USD 1.18
(-6.75%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -31.29 Million USD | -34.76% |
2022 | 21.02 Million USD | 25.95% |
2021 | 19.21 Million USD | 732.75% |
2020 | 4.57 Million USD | -29.23% |
2019 | 3.13 Million USD | 336.02% |
2018 | 909.12 Thousand USD | 99.0% |
2017 | 126.8 Thousand USD | 108.66% |
2016 | -2.8 Million USD | -121.4% |
2015 | 337.42 Thousand USD | 49.76% |
2014 | -1.35 Million USD | -462.13% |
2013 | 1.1 Million USD | 18.39% |
2012 | 892.75 Thousand USD | -40.23% |
2011 | 1.32 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 4.99 Million USD | 111.96% |
2024 Q2 | 6.69 Million USD | 34.23% |
2023 Q2 | 2.18 Million USD | -33.45% |
2023 Q4 | 3.71 Million USD | 136.28% |
2023 Q1 | 3.28 Million USD | -10.72% |
2023 FY | - USD | -34.76% |
2023 Q3 | 1.57 Million USD | -28.2% |
2022 Q4 | 3.68 Million USD | 30.83% |
2022 Q1 | 3.94 Million USD | -10.29% |
2022 Q2 | 5.78 Million USD | 46.65% |
2022 FY | - USD | 25.95% |
2022 Q3 | 2.81 Million USD | -51.31% |
2021 Q3 | 5.45 Million USD | 53.09% |
2021 FY | - USD | 732.75% |
2021 Q1 | 2.07 Million USD | -39.23% |
2021 Q2 | 3.56 Million USD | 71.59% |
2021 Q4 | 4.39 Million USD | -19.46% |
2020 Q4 | 3.41 Million USD | 120.87% |
2020 FY | - USD | -29.23% |
2020 Q3 | 1.54 Million USD | 231.11% |
2020 Q2 | -1.18 Million USD | -113.47% |
2020 Q1 | -552.86 Thousand USD | -127.04% |
2019 Q3 | 725 Thousand USD | 204.23% |
2019 Q4 | 2.04 Million USD | 181.97% |
2019 FY | - USD | 336.02% |
2019 Q1 | 468.9 Thousand USD | 1592.49% |
2019 Q2 | 238.3 Thousand USD | -49.18% |
2018 Q3 | -1.13 Million USD | -226.73% |
2018 Q2 | 891.7 Thousand USD | 8.97% |
2018 Q1 | 818.3 Thousand USD | 335.67% |
2018 FY | - USD | 99.0% |
2018 Q4 | 27.7 Thousand USD | 102.45% |
2017 Q3 | 427.42 Thousand USD | 55.81% |
2017 FY | - USD | 108.66% |
2017 Q1 | -584.23 Thousand USD | 74.31% |
2017 Q4 | 187.82 Thousand USD | -56.06% |
2017 Q2 | 274.32 Thousand USD | 146.96% |
2016 Q4 | -2.27 Million USD | -579.67% |
2016 Q2 | -220.13 Thousand USD | 63.54% |
2016 FY | - USD | -121.4% |
2016 Q3 | -334.66 Thousand USD | -52.02% |
2016 Q1 | -603.75 Thousand USD | -844.09% |
2015 Q4 | 81.14 Thousand USD | 116.48% |
2015 Q3 | -492.33 Thousand USD | -33.98% |
2015 Q2 | -367.46 Thousand USD | 54.9% |
2015 Q1 | -814.81 Thousand USD | 36.54% |
2015 FY | - USD | 49.76% |
2014 Q2 | -95.67 Thousand USD | -110.21% |
2014 Q1 | -45.51 Thousand USD | -108.6% |
2014 Q3 | -1.6 Million USD | -1578.01% |
2014 Q4 | -1.28 Million USD | 20.02% |
2014 FY | - USD | -462.13% |
2013 Q3 | 235.19 Thousand USD | 625.93% |
2013 Q1 | 203.41 Thousand USD | -23.26% |
2013 Q2 | 32.39 Thousand USD | -84.07% |
2013 Q4 | 529.22 Thousand USD | 125.02% |
2013 FY | - USD | 18.39% |
2012 FY | - USD | -40.23% |
2012 Q3 | 309.59 Thousand USD | 0.0% |
2012 Q4 | 265.07 Thousand USD | -14.38% |
2011 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Augmedix, Inc. | -17.68 Million USD | -76.97% |
BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 108.952% |
CareCloud, Inc. | -31.29 Million USD | -0.0% |
HealthEquity, Inc. | 282.41 Million USD | 111.079% |
iCoreConnect Inc. | -11.87 Million USD | -163.397% |
Inovalon Holdings, Inc. | 186.56 Million USD | 116.772% |
Nutex Health, Inc. | -14.58 Million USD | -114.589% |
Omnicell, Inc. | 60.69 Million USD | 151.557% |
OneMedNet Corporation | -11.97 Million USD | -161.387% |
Progyny, Inc. | 64.46 Million USD | 148.538% |
Renalytix Plc | -28.52 Million USD | -9.709% |
Schrödinger, Inc. | -171.89 Million USD | 81.797% |
Simulations Plus, Inc. | 6.13 Million USD | 610.357% |
SOPHiA GENETICS SA | -70.7 Million USD | 55.743% |
Streamline Health Solutions, Inc. | -12.81 Million USD | -144.148% |
Ontrak, Inc. | -14.41 Million USD | -117.05% |
GE HealthCare Technologies Inc. | 3.56 Billion USD | 100.879% |
Sharecare, Inc. | -67.25 Million USD | 53.475% |
Aclarion, Inc. | -4.14 Million USD | -655.722% |
CareMax, Inc. | -590.46 Million USD | 94.701% |
Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | -493.169% |
Forian Inc. | 2.75 Million USD | 1237.698% |
Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | -493.169% |
HeartBeam, Inc. | 675 Thousand USD | 4735.556% |
GeneDx Holdings Corp. | -136.46 Million USD | 77.07% |
SCWorx Corp. | -3.97 Million USD | -687.23% |
Minerva Surgical, Inc. | -20.07 Million USD | -55.881% |
Definitive Healthcare Corp. | -241.22 Million USD | 87.029% |
10x Genomics, Inc. | -205.11 Million USD | 84.745% |
Zhongchao Inc. | -4.9 Million USD | -538.265% |
Accolade, Inc. | -71.19 Million USD | 56.049% |
MSP Recovery, Inc. | -69.22 Million USD | 54.797% |
R1 RCM Inc. | 426.2 Million USD | 107.342% |
Spok Holdings, Inc. | 26.29 Million USD | 218.987% |
Privia Health Group, Inc. | 27.18 Million USD | 215.113% |
EUDA Health Holdings Limited | -8.3 Million USD | -276.972% |
TruBridge, Inc. | -15.39 Million USD | -103.301% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 108.952% |
Sharecare, Inc. | -67.25 Million USD | 53.475% |
Health Catalyst, Inc. | -66.46 Million USD | 52.92% |
GoodRx Holdings, Inc. | 108.82 Million USD | 128.753% |
Premier, Inc. | 286.08 Million USD | 110.937% |
HealthStream, Inc. | 59.58 Million USD | 152.511% |
Certara, Inc. | 23.84 Million USD | 231.228% |
GeneDx Holdings Corp. | -136.46 Million USD | 77.07% |
Ontrak, Inc. | -14.41 Million USD | -117.05% |
SHL Telemedicine Ltd. | 3.28 Million USD | 1052.942% |
CareCloud, Inc. | -31.29 Million USD | -0.0% |
EUDA Health Holdings Limited | -8.3 Million USD | -276.972% |
HeartBeam, Inc. | 675 Thousand USD | 4735.556% |
Mangoceuticals, Inc. | -9.18 Million USD | -240.57% |
CareMax, Inc. | -590.46 Million USD | 94.701% |
Healthcare Triangle, Inc. | -4.1 Million USD | -662.427% |
National Research Corporation | 45.98 Million USD | 168.044% |
Aclarion, Inc. | -4.14 Million USD | -655.722% |
OptimizeRx Corporation | -21.3 Million USD | -46.844% |